Mixed methods evaluation of Asthma Link implementation: A community-clinical linkage intervention of school supervised asthma therapy
Authors
Ryan, Grace WNanavati, Janvi
Mendoza Martinez, Daniel
Pereira, Kali
Almeida, John
Spano, Michelle
Gerald, Lynn
Lemon, Stephenie C
Pbert, Lori
Trivedi, Michelle
Student Authors
Janvi NanavatiDaniel Mendoza Martinez
Kali Pereira
John Almeida
UMass Chan Affiliations
PediatricsPopulation and Quantitative Health Sciences
Prevention Research Center
T.H. Chan School of Medicine
Document Type
PosterPublication Date
2023-12-12
Metadata
Show full item recordAbstract
Background: Asthma Link is a community-clinical linkage intervention wherein children with poorly controlled asthma receive school-supervised asthma therapy. This intervention supports collaboration between medical providers who identify and enroll children, families who consent and bring medications to their child’s school, and school nurses who supervise daily preventive medication administration. This intervention has shown promise in reducing asthma exacerbations, however implementation outcomes (adoption and acceptability), have not previously been assessed. Methods: Using mixed-methods, we assessed adoption (defined as uptake of multiple process steps leading to children receiving supervised preventive asthma medication at school) and acceptability of Asthma Link. We generated descriptive statistics from surveys with practice staff(n=8), parents of enrolled children(n=29), and school nurses(n=14), as well as data tracking logs. We also interviewed medical providers and staff(n=8) and used rapid qualitative analysis. Finally, we triangulated qualitative and quantitative findings. Findings: Regarding adoption, first, 100% of trained providers offered the program. Providers identified 66 eligible children and enrolled 47%(n=31). The preventive asthma medication was brought into school an average of 2.6 (SD=2.9) weeks after enrollment and medication was available to students for 95% of the time they were in school over twelve months of enrollment. One medical provider reflected on adoption: “It’s not for lack of trying...but the family is not willing to.” Acceptability was high in surveys and interviews: 77% of providers, 78% of parents, and 79% of school nurses strongly agreed that the program was acceptable. One provider reported “It was an excellent, excellent program.” Implications for D&I Research: We found excellent adoption of Asthma Link once children were enrolled and high acceptability of the intervention. Qualitative interviews provided important context to quantitative implementation data and will inform future adaptations to promote intervention uptake. For example, we will develop implementation strategies to better support parents, who are identified by providers as “not willing” to participate, which could increase adoption. The use of mixed-methods to assess implementation outcomes at the level of intervention deliverers (medical providers, practice staff, school nurses) and end-users (parents) provided nuanced, actionable information on implementation. This approach should be considered in future implementation evaluations.Source
Ryan GW, Nanavati J, Martinez DM, Pereira K, Almeida J, Spano M, Gerald L, Lemon SC, Pbert L. Trivedi M. Mixed methods evaluation of Asthma Link implementation: A community-clinical linkage intervention of school supervised asthma therapy. Poster presentation at: Conference on the Science of Dissemination and Implementation in Health, 2023.DOI
10.13028/nbt5-xp98Permanent Link to this Item
http://hdl.handle.net/20.500.14038/53413Funding and Acknowledgements
This work was supported by the National Heart, Lung, and Blood Institute #5K23HL15034. Funders had no involvement in this work.Rights
Copyright © 2023 The Author(s); Attribution-NonCommercial 4.0 InternationalDistribution License
http://creativecommons.org/licenses/by-nc/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/nbt5-xp98
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2023 The Author(s); Attribution-NonCommercial 4.0 International